4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-17-009161
Options or other derivatives
- Senior VP - CCO acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Powell Lynne · Senior VP - CCO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-02-27 | Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) | +150,000 | $5.51 | 2027-02-27 | 150,000 | 150,000 | D |
Loading xslF345X03/form4.xml…